Clinical Trials Browser

Phase 1/2 × peginterferon alfa-2a × 1 year × Clear all

NCT07288112 2026-02-23

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

Phase 1/2 Recruiting

Melanoma